Crispr Therapeutics Ag (CRSP)

概要ニュース株価時系列オプションチェーン Financials なぜCRSPが下落しているのか？ディスカッション予測

なぜCrispr Therapeutics Ag（CRSP）の株価が下がっていますか？

2026-07-16 の取引セッション中に、Crispr Therapeutics Ag (CRSP) 株の 5.45% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。

2023-11-13:

CRISPR Therapeutics AG Stock (CRSP) dropped by 2.16% from $53.16 to $52.01 in the trading on Monday November 13, 2023. The reason why CRSP stock down today is due to the recent lower price target by the analysts.

On Monday, Morgan Stanley analyst Terence Flynn maintained CRISPR Therapeutics with an Underweight and lowered the price target from $43 to $42.
Last Tuesday, RBC Capital analyst Luca Issi maintains CRISPR Therapeutics with a Sector Perform and lowered the price target from $55 to $50.
Needham analyst Gil Blum maintained CRISPR Therapeutics with a Buy and lowered the price target from $88 to $85.

2023-10-02:

CRISPR Therapeutics AG Stock (CRSP) dropped by 6.57% from $45.39 to 42.41 in the trading on Monday October 2, 2023. The reason why stock CRSP is down is due to upcoming FDA decisions for exa-cel. The company is awaiting FDA decisions on its exa-cel gene therapy for sickle cell disease and beta-thalassemia. These decisions are anticipated in the near future, and a few investors might be selling their CRSP shares before the decisions are made, which cause CRSP stock down.